Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

A Schistosoma japonicum vaccine expression vector secreted and expressed by attenuated Salmonella and its application

A Salmonella, secretion and expression technology, applied in the field of Schistosoma japonicum vaccine expression vector, can solve the problems of limiting the effective presentation of antigens, and achieve the effects of high-efficiency secretion, high-efficiency expression and low cost

Active Publication Date: 2011-12-14
NANJING UNIV
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This membrane-encased vesicle structure largely limits the efficient presentation of antigens

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A Schistosoma japonicum vaccine expression vector secreted and expressed by attenuated Salmonella and its application
  • A Schistosoma japonicum vaccine expression vector secreted and expressed by attenuated Salmonella and its application
  • A Schistosoma japonicum vaccine expression vector secreted and expressed by attenuated Salmonella and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0031] Taking the Schistosoma japonicum bivalent antigen sj23LHDGST (the large hydrophilic region of the sj23 molecule and the fusion protein of GST) as the delivery antigen as an example:

[0032] 1. Construction of secretory expressed vaccine vectors:

[0033]Antigen molecule sj23LHD-GST is secreted by Salmonella type Ⅲ secretion system and hemolysin secretion system respectively.

[0034] a) Construction of type III secretion expression vector: through the N-terminal 1-104 amino acids of type III secretion effector molecule sopE (sopE 1-104 ) is coupled with the antigen molecule sj23LHD to realize its secretion; the Escherichia coli nitrate reductase (nirB) promoter is used to express the type III secreted antigen. The nirB promoter was obtained by PCR method: the primer sequences were: P1: 5'-cccctcgagggttaccggcccgatcg-3'; P2: 5'-cccggatccaccgcctaccttaacgattc-3'; 50 ng of Escherichia coli genomic DNA was used as a template. The obtained fragments had XhoI and BamHI restr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of biotechnology and particularly relates to a schistosoma japonica vaccine salmonella secretion expression vector, which is a recombinant salmonella expression vector that is controlled by a bacterial promoter, guided by effector protein secreted by salmonella and secretion signal of the effector protein and used for secretion expression of schistosoma japonica antigen. The schistosoma japonica vaccine salmonella secretion expression vector can induce secretion expression of a schistosoma japonica vaccine in a hypoxic microenvironment in antigen presenting cells, can exist in vivo stably and continuously and is insusceptible to being lost. The schistosoma japonica vaccine salmonella secretion expression vector, by using an attenuated strain as a carrier, can perform the antigen carrying of the recombinant vaccine representing bacteria by means of oral taking. The schistosoma japonica vaccine salmonella secretion expression vector can be used for preparing schistosoma japonica vaccine for oral taking for preventing and treating schistosomiasis.

Description

technical field [0001] The invention belongs to the field of biological technology, and in particular relates to an expression vector of a schistosoma japonicum vaccine secreted and expressed by attenuated Salmonella and its application. Background technique [0002] Schistosomiasis is a zoonotic parasitic disease that seriously endangers the health of humans and livestock. About 600 million people around the world live in schistosomiasis-endemic areas, 200 million people are infected, 120 million people have clinical symptoms, and the annual death toll reaches dozens Ten thousand. Since the development of the special drug praziquantel, the prevalence of schistosomiasis has been alleviated through group chemotherapy, but the spread of schistosomiasis is still continuing, and the number of patients is still increasing. Moreover, the resistance to chemical drugs such as praziquantel also greatly affects the prevention and control of schistosomiasis (McManus DP, Clin Microbiol...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/74A61K39/00A61K48/00A61P33/12C12R1/42
CPCY02A50/30
Inventor 华子春陈果
Owner NANJING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com